Dirk Haasner's most recent trade in Ovid Therapeutics Inc was a trade of 100,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 17, 2020.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ovid Therapeutics Inc | Dirk Haasner | SVP, Global Regulatory Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2020 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Ovid Therapeutics Inc | Dirk Haasner | SVP, Global Regulatory Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2020 | 20,000 | 20,000 | - | - | Stock option (Right to Buy) |